Thrombosis

Latest News

Low Forced Expiratory Volume in Chronic Thromboembolic Pulmonary Hypertension

Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?

Noncontrast CT for Mechanical Thrombectomy in Extended Time Window: The Outcomes

In a multinational cohort study, researchers compared the clinical outcomes of patients selected for mechanical thrombectomy by noncontrast CT vs those selected by CTP or MRI in the extended time window.

Can a Mobile Health Tech Program Help Patients With Atrial Fibrillation, Multimorbidity?

Researchers investigated whether a mobile health technology program for older adults with AF and multimorbidity would help decrease AF-related adverse events.

Pediatric-Onset IBD Associated With Increased Risk for VTE

Investigators examined the incidence of and risk factors for venous thromboembolism in pediatric patients with IBD compared with the general pediatric population.

Some Patients With COVID-19 First Present With Arterial Thrombosis

Researchers aimed to study the clinical characteristics, treatments, and outcomes of unexpected acute arterial thrombosis in patients with COVID-19.

Risk Factors ID’d for Postdischarge Thrombosis in COVID-19 Patients

Risk factors for postdischarge VTE include history of VTE, peak D-dimer >3 µg/mL, predischarge CRP >10 mg/dL

Rates of Recurrent VTE Compared for Apixaban, Rivaroxaban

Among new users, rates of recurrent venous thromboembolism, GI and intracranial bleeding lower with apixaban than rivaroxaban

Oral Milvexian Promising for Prevention of VTE

In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin.

ACS Risk Biomarkers Significantly Increase After mRNA COVID-19 Vaccine

Increases in PULS Cardiac Test scores after mRNA vaccinations suggest a significantly higher risk of developing acute coronary syndrome, according to findings presented at AHA 2021.

DOACs and VKAs Similarly Efficacious for Black Patients vs General Population

In a landmark trial presented at AHA 2021, researchers aimed to understand the safety and efficacy of direct oral anticoagulants vs vitamin K antagonists in Black patients with non-valvular atrial fibrillation and venous thromboembolism.